FYFang Yu

Fang Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fang Yu has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Tongqian Wu

    Clinical Research Center, Affiliated Hospital of Guizhou Medical University

    7 shared publications
  • Jing Li

    Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University

    6 shared publications
  • Shirong Yan

    Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University

    5 shared publications
  • Zou Xiang

    Department of Health Technology and Informatics, Faculty of Health and Social Science, The Hong Kong Polytechnic University, Hong Kong, China

    5 shared publications
  • Jingjing He

    School of Laboratory Science, Guizhou Medical University, Guiyang, China

    4 shared publications
  • Xue Shen

    Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyang, China

    4 shared publications

Latest Publications

  • Open Access

    Respiratory Klebsiella pneumoniae infection transiently alters neutrophil responsiveness and enhances distal allergic inflammation

    by Xilan Xiao, Jing Li, Tongqian Wu, Shirong Yan, Yan Wang, Rongtao Yang, Ziqian Guo, Wengui Gong, Zhicheng Hu, Fang Yu

    Background: Microbial exposure at respiratory interfaces shapes host defense, but whether prior localized bacterial infection can alter innate immune responsiveness and modulate subsequent allergic inflammation at distal sites remains unclear. This study investigated the impact of prior respiratory Klebsiella pneumoniae (KP) infection on distinct models of cutaneous allergic inflammation and the contribution of neutrophils to this cross-tissue modulation. Methods: Mice were intratracheally infected with KP subsequently subjected to passive cutaneous anaphylaxis (PCA), oxazolone-induced contact hypersensitivity, or fluorescein isothiocyanate (FITC)-induced contact hypersensitivity. Neutrophil depletion (anti-Ly6G) and adoptive transfer of bone marrow neutrophils from infected or naïve donors were performed. Neutrophil phenotype (CXCR2, CD62L) and function were assessed by flow cytometric analysis and ex vivo LPS-stimulated cytokine production (TNF-α, IL-1β, IL-6). Allergic responses were evaluated by ear swelling, vascular permeability (Evans blue), mast cell degranulation, histamine levels, and inflammatory cytokine profiles. Results: At day 7 after respiratory KP infection, bacterial loads in bronchoalveolar lavage fluid and blood were nearly undetectable, whereas inflammatory cytokines, including TNF-α, IL-1β, and IL-6, remained elevated in lung tissue, bronchoalveolar lavage fluid, and serum. Bone marrow neutrophils from KP-infected mice showed altered CXCR2 and CD62L expression and produced higher levels of TNF-α, IL-1β, and IL-6 after ex vivo LPS stimulation, suggesting enhanced neutrophil responsiveness during the post-infectious phase. Prior KP infection aggravated distal allergic inflammation in the PCA and oxazolone models, as shown by increased ear swelling, Evans blue extravasation, mast cell degranulation, histamine production, neutrophil infiltration, and inflammatory mediator expression. In contrast, the additional effect of KP infection was more limited in the FITC-induced contact hypersensitivity model, indicating a model-dependent response. In the PCA model, neutrophil depletion attenuated KP-enhanced allergic inflammation, whereas adoptive transfer of neutrophils from KP-infected donors restored and enhanced PCA responses more strongly than transfer of control neutrophils. Conclusion: Respiratory KP infection is associated with post-infectious neutrophil priming and enhanced distal allergic inflammation in a model-dependent manner. These findings suggest that prior bacterial respiratory infection may influence subsequent allergic responses through altered neutrophil responsiveness, with effects that are context-dependent rather than universal across all hypersensitivity models.

  • Open Access

    A comprehensive dataset comparing endogenous and exogenous HIL interference across diverse clinical immunoassays

    by Yu Chen, Yujia Li, Yijiao Tang, Shixiao Song, Yan Wang, Xue Shen, Qingqing Wu, Yujie Tan, Fang Yu

    We present a dataset quantifying hemolysis, lipemia, and icterus (HIL) interferences across a range of immunoassays, including multiplex cytokine assays. The collection comprises analytical measurements from electrochemiluminescence and flow fluorescent platforms, contrasting autologous and endogenous samples with conventional commercial exogenous interference models. This study compiled the measured concentrations of biomarkers such as interleukins, NSE, folate, insulin, ProGRP, calcitonin, osteocalcin, and total P1NP in samples with varying degrees of interference, thereby highlighting significant analytical discrepancies between artificially simulated and genuine clinical samples, particularly in lipemic samples. Because this dataset captures the impact of both endogenous and exogenous interferences, it is highly suitable for clinical chemistry studies assessing the limitations of exogenous methods. In addition to the raw comparative data, we provide derived reference charts and correction formulas for hemolysis-sensitive analytes. Ultimately, these resources extend the dataset's utility, offering practical tools for clinical laboratories to refine interference validation protocols and minimize unnecessary sample rejections.

  • Open Access

    SNX10 regulates the proliferation, apoptosis and cell cycle of acute B lymphoblastic leukemia cells via the PI3K/Akt signaling pathway

    by Chenyu Wang, Xiulan Yang, Xue Shen, Shirong Yan, Jing Li, Yan Wang, Tian Tao, Tongqian Wu, Qian Kang, Fang Yu

    B‑cell acute lymphoblastic leukemia (B‑ALL) is a type of acute lymphoblastic leukemia that originates from B cells. It typically occurs in children and adolescents, but it can also appear in adults. Sorting nexin 10 (SNX10) has recently been identified as a significant regulatory factor in various tumors, although its specific roles remain contested. However, its function in B‑ALL has not been previously explored. The present study investigated the role of SNX10 in B‑ALL pathogenesis. Bioinformatics analysis identified SNX10 as a Core Hub gene in the B‑ALL signaling network, with significantly reduced expression in patients with B‑ALL. These findings were corroborated through analysis of clinical bone marrow samples and B‑ALL cell lines. Functional in vitro studies revealed that SNX10 knockdown markedly inhibited B‑ALL cell proliferation, increased apoptosis, and arrested cells in the G0/G1 phase. By contrast, SNX10 overexpression enhanced cell proliferation, suppressed apoptosis and promoted G2/M phase progression. Proteomic analysis further implicated the PI3K/Akt signaling pathway in mediating the effects of SNX10. Specifically, SNX10 overexpression increased the phosphorylation levels of PI3K and Akt, while SNX10 knockdown had the opposite effect. In vivo experiments demonstrated that elevated SNX10 expression accelerated leukemia progression in a mouse model. Collectively, these findings highlighted the pivotal role of SNX10 in promoting B‑ALL cell proliferation via the PI3K pathway, highlighting its potential as a therapeutic target for B‑ALL and providing a foundation for future investigations.

  • Open Access

    S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway

    by He Jingjing, Wu Tongqian, Yan Shirong, Ma Lan, Li Jing, Mo Shihui, Yan Haijian, Yu Fang


    • 1 September 2024
      • Vol. 40  (9) , 826-833

    [Expression of S100A4 in mast cells and diagnostic values of serum S100A4 in allergic asthma].

    by Shihui Mo, Tian Tao, Chenyu Wang, Shirong Yan, Jing Li, Tongqian Wu, Fang Yu

    Objective To preliminarily investigate the potential involvement of the calcium-binding protein S100A4 in the lipid metabolism of mast cells and its clinical significance in allergic asthma. Methods The allergic asthma-related expression matrix, GSE213085, was downloaded from the GEO database, and the data visualization were visualized by the R package. C57 mast cells were used for further knockdown of S100A4 by lentivirus transfection. Western blot analysis and real-time fluorescence quantitative PCR (RT-qPCR) were used to measure the levels of S100A4 protein and mRNA, respectively. Furthermore, the mRNA expression of lipid metabolic-relevant molecules ATP citrate synthase (ACLY), acetyl-CoA-carboxylase 1 (ACC1), CD36, solute carrier family 27a member 6 (SCL27a6), and peroxisome proliferator-activated receptor alpha (PPARα) were evaluated using RT-qPCR. The peripheral blood was collected from patients with allergic asthma and healthy control subjects, and the levels of serum S100A4 were measured by ELISA. The receiver operating characteristic (ROC) curve was plotted to analyze the diagnostic efficacy of S100A4 for the disease, and the area under the curve (AUC) was calculated. Results 26 225 cells were identified using the scRNA dataset GSE213085, and mast cells were extracted for subsequent analyses. Genes for mast cell-markers were concentrated in metabolism-related pathways, as revealed by functional enrichment analysis. S100A4 knockdown in mast cells suppressed the expression of ACLY, ACC1, CD36, SCL27a6, and PPARα. Increased levels of S100A4 were observed in the serum of patients with allergic asthma compared to healthy controls. The ROC curve showed that serum S100A4 has diagnostic efficacy for allergic asthma (AUC=0.746). Conclusion S100A4 may be involved in the regulation of the lipid metabolism of mast cells, and may contribute to the personalized diagnosis and treatment of patients with allergic asthma.

  • Open Access

    Mast cells are identified in the lung parenchyma of feral mice which can be recapitulated in naturalized laboratory mice

    by Yu-Wen Yeh, Arka Sen Chaudhuri, Ling Zhou, Fang Yu, Preben Boysen, Zou Xiang

    Background: It is well documented that laboratory mice bred and maintained in ultra-hygienic specific pathogen-free (SPF) barriers display reduced richness and complexity of microbiota compared with wild mice. The laboratory mice profoundly lack lung parenchymal mast cells. Hence, we aimed to investigate the lung distribution of mast cells in free-living feral mice. Methods: Feral house mice were trapped in South-Eastern Norway and Hemtabad, West Bengal, India. C57BL/6 laboratory mice were bred in a purposefully built, closed environment with bedding material obtained from the natural environment with wild rodent infestation in order to normalize the gut microbiota of these laboratory mice to that of the wild mice, and the offspring were collected for study at 8 weeks of age. Results: Mast cells were easily identified at a substantial density in the lung parenchymal tissues of feral mice from both Norway and India, which stands in clear contrast to the rare distribution of lung parenchymal mast cells in the conventional laboratory SPF mice. Consistently, wild mice also expressed higher pulmonary levels of stem cell factor, a critical growth factor for mast cell survival. Higher levels of histamine were recorded in the lung tissues of the wild mice. Interestingly, “naturalized” C57BL/6 laboratory mice which spent their entire life in a semi-natural environment developed lung parenchymal mast cells at an appreciable density. Conclusion: Our observations support that environmental factors, possibly through modulation of microbiota, may impact the tissue distribution of mast cells in mouse lung tissues.

  • S100A4 reprofiles lipid metabolism in mast cells via RAGE and PPAR-γ signaling pathway

    by Mo Shihui, Yan Shirong, Li Jing, He Jingjing, Wu Tongqian, Tao Tian, Wang Chenyu, Yu Fang


  • Open Access

    Human placental extract suppresses mast cell activation and induces mast cell apoptosis

    by Tongqian Wu, Jingjing He, Shirong Yan, Jing Li, Ke Chen, Dingshan Zhang, Mingliang Cheng, Zou Xiang, Yu Fang

    Background: Human placental extract (HPE) has been documented to facilitate the healing of certain disorders including allergy. However, the effects of HPE on the functionality of mast cells, a critical cell type in allergic diseases, have not been reported. Methods: To investigate the effects of HPE on the regulation of allergy with respect to the biological functions of mast cells, the mast cell line C57 or HMC-1 cells were treated with HPE followed by the assessment of cell proliferation, apoptosis, activation, chemotaxis and phagocytosis. Mouse peritoneal mast cells were also investigated for their responses to induction of apoptosis by HPE in vivo. Furthermore, the effect of HPE on mast cell degranulation was confirmed using the passive cutaneous anaphylaxis (PCA) assay, an acute allergy model. Results: HPE was capable of suppressing mast cell proliferation and inducing mast cell apoptosis. Mast cell degranulation in response to compound 48/80- or anti-DNP IgE and DNP-mediated activation was suppressed. In addition, treatment with HPE compromised the production of cytokines by mast cells and cell chemotaxis. These observations were consistent with the dampened passive cutaneous anaphylaxis (PCA) assay following treatment with HPE. Conclusion: This study revealed a suppressive effect of HPE on overall mast cell activities, suggesting a potential regulatory role of HPE on the alleviation of allergic diseases through mast cells.


  • Open Access

    Relationship Between the Expression of PD-1 and CTLA-4 on T Lymphocytes and the Severity and Prognosis of Sepsis

    by Lang Wang, Zhiqi Zhang, Xingxiang Chen, Fang Yu, Hai Huang, Xue Shen, Yujie Tan, Qingqing Wu

    Purpose: The study aimed to investigate the relationship between the expression of PD-1 and CTLA-4 on the surface of peripheral blood T lymphocyte subsets in patients with sepsis and the severity and prognosis of the disease. Patients and Methods: The study included patients with sepsis who were admitted to the intensive care unit. The expression of PD-1 and CTLA-4 on T lymphocyte subsets was detected by flow cytometry, and the severity of sepsis was assessed using the SOFA score. Results: The expression of PD-1 on CD4+T cells, PD-1 on Tregs, and CTLA-4 on Tregs increased with the severity of the disease (P< 0.05). Multivariate logistic regression analysis showed that PD-1 expression on CD4+T cells, CTLA-4 expression on Tregs, and the SOFA score were independent risk factors for 28-day mortality in patients with sepsis (P< 0.05). The area under the curve of the SOFA score combined with the expression of PD-1 on CD4+T cells and CTLA-4 on Treg cells was significantly higher than any single indicator (P< 0.05). Patients with high expression of PD-1 on CD4+T cells (> 31.25%) and CTLA-4 on Tregs (> 12.64%) had a lower 28-day survival rate (P< 0.05). Conclusion: The increased expression of PD-1 and CTLA-4 on CD4+T cells and Tregs is significantly associated with the severity and prognosis of sepsis patients. The combination of the SOFA score and the expression of PD-1 on CD4+T cells and CTLA-4 on Tregs can further improve the prognostic predictive value. These findings may be promising biomarkers for prognostic assessment, risk stratification, and identification of immunosuppression in patients with sepsis.